Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...
The blue-chip Dow Jones Industrial Average closed at a record high as a subdued inflation report stoked hopes for more ...
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
U.S. stocks closed another record-setting week with a muted performance Friday, as hope built on Wall Street that the U.S. economy can manage the rare feat of suppressing high inflation without ...
The Dow Jones Industrial Average reached a record high following a modest inflation report, spurring hopes for additional ...
The blue-chip Dow Jones Industrial Average closed at a record high today as investors welcomed a subdued inflation report ...
The Dow Jones Industrial Average edged up to another record high while declines in tech stocks pulled other indexes lower.
In a breakthrough for people with schizophrenia, the FDA has approved a new oral medication for adults. Unlike traditional antipsychotic drugs, the medication, which will be marketed under the name ...
The Dow Jones Industrial Average closed at a record high, driven by investor optimism following a subdued inflation report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback